Is there any reason to suspect that all subjects w
Post# of 144499
![](/assets/46931549/no_avatar_available_thumb.jpg)
My expectation is that leronlimab will go and bind to CCR5 wherever it may be, and there will be very little / no variation between subjects in CCR5 RO.
https://www.sciencedirect.com/science/article...1220323055
Figure 2 E and 2 E (another typo / mistake in that figure, sigh).
All 10 get to 100% RO at day 14. All are 80% at day 7 (2D) with a few stragglers (2E).
What would explain why LL blocks some subjects' CCR5 but not others'?
Are you saying if not 100% RO at day 14, then give another dose at day 21?
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)